Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.79
+0.17 (0.44%)
At close: Jul 19, 2024, 4:00 PM
39.01
+0.22 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CALT Employees
Calliditas Therapeutics AB (publ) had 217 employees as of December 31, 2023. The number of employees increased by 39 or 21.91% compared to the previous year.
Employees
217
Change (1Y)
39
Growth (1Y)
21.91%
Revenue / Employee
$551,756
Profits / Employee
-$213,127
Market Cap
1.04B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Ironwood Pharmaceuticals | 267 |
| Tarsus Pharmaceuticals | 244 |
| Collegium Pharmaceutical | 197 |
| Innoviva | 112 |
| Cullinan Oncology | 85 |
| Tyra Biosciences | 49 |
| Enliven Therapeutics | 46 |
CALT News
- 18 days ago - Launch of Phase 3 clinical trial with Nefecon in Japan - PRNewsWire
- 4 weeks ago - Calliditas provides setanaxib patent update - PRNewsWire
- 4 weeks ago - Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ) - PRNewsWire
- 6 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of Shareholders - GlobeNewsWire
- 6 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT on Behalf of Shareholders - Accesswire
- 6 weeks ago - STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger and Expiring Tender Offer - AKLI and CALT - Accesswire
- 6 weeks ago - STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB – CALT - GlobeNewsWire
- 6 weeks ago - SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate MODN, CALT - Accesswire